Mostrando 9 resultados de: 9
Filtros aplicados
Publisher
International Journal of Stroke(2)
Stroke(2)
Cerebrovascular Diseases(1)
JAMA Neurology(1)
Journal of Human Hypertension(1)
Área temáticas
Enfermedades(7)
Farmacología y terapéutica(3)
Fisiología humana(3)
Medicina y salud(3)
Ginecología, obstetricia, pediatría, geriatría(2)
Origen
scopus(9)
Blood pressure variability and outcome in acute ischemic and hemorrhagic stroke: a post hoc analysis of the HeadPoST study
ArticleAbstract: The Head Positioning in Acute Stroke Trial (HeadPoST) is a pragmatic, international, cluster crossovPalabras claves:Autores:Arima H., Billot L., Chalmers J., De Silva H.A., Hackett M.L., Lavados P.M., Lee T.H., Mead G.E., Middleton S., Minhas J.S., Moullaali T.J., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Robinson T.G., S Anderson C., Wang X., Watkins C.L.Fuentes:scopusApplicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry
ArticleAbstract: Background: Randomized controlled trials provide high-level evidence, but the necessity to include sPalabras claves:acute ischemic stroke, Alteplase, Clinical trial, health outcomes, thrombolysisAutores:Arima H., Bath P.M.W., Bray B.D., Broderick J.P., Chalmers J., Durham A.C., Kim J.S., Lavados P.M., Lee T.H., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Paley L., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., Rudd A.G., S Anderson C., Sharma V.K., Sprigg N., Wang J.G., Wang X., Woodward M.Fuentes:scopusInfluence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis
ArticleAbstract: Background and Purpose - Renal dysfunction (RD) is associated with poor prognosis after stroke. We aPalabras claves:Glomerular Filtration Rate, Hypertension, intracranial hemorrhages, ODDS RATIO, strokeAutores:Carr S.J., Chalmers J., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Octavio Marques Pontes-Neto, Olavarria V.V., Ricci S., Robinson T.G., Rodriguez J.A., S Anderson C., Sato S., Sharma V.K., Wang X., Woodward M.Fuentes:scopusLow-Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)
Conference ObjectAbstract: Background and Purpose'Many patients receiving thrombolysis for acute ischemic stroke are on prior aPalabras claves:aspirin, Brain Infarction, Hypertension, intracranial hemorrhages, Tissue plasminogen activatorAutores:Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Wang J.G., Wang X., Woodward M.Fuentes:scopusLow-dose versus standard-dose intravenous alteplase in acute ischemic stroke
ArticleAbstract: BACKGROUND: Thrombolytic therapy for acute ischemic stroke with a lower-than-standard dose of intravPalabras claves:Autores:Arima H., Bath P.M.W., Billot L., Broderick J.P., Cao Y., Chalmers J., Chen G., Chen X., Demchuk A.M., Donnan G.A., Huang Y., Kim J.S., Lavados P.M., Lee T.H., Levi C., Li Q., Lindley R.I., Martins S.O., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., Roffe C., S Anderson C., Sharma V.K., Silva-Sieger F.A., Thang N.H., Wang J.G., Wang X., Woodward M.Fuentes:scopusLow-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial
ArticleAbstract: IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the stPalabras claves:Autores:Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Li Q., Lindley R.I., Martins S.O., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Thang N.H., Wang J.G., Wang X., Woodward M.Fuentes:scopusIntensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
ArticleAbstract: Background: Systolic blood pressure of more than 185 mm Hg is a contraindication to thrombolytic trePalabras claves:Autores:Arima H., Armenis M., Bai X., Baig M.A., Bath P.M.W., Benito D., Billot L., Blacklock N., Bousser M.G., Broderick J.P., Cao Y., Carcel C., Chalmers J., Chen G., Chen R., Chen X., Cong Y., Coutts S., Cui B., Delcourt C., Demchuk A.M., Deng H., Donnan G.A., Donnelly P., Durham A.C., Fuentes-Patarroyo S.X., Glass P., Gordon P., Guo Y., Hankey G.J., Haunton V., He R., Hirakawa Y., Huang Y., Ivanova E., Jenson K., Jia H., Kim J.S., Knight E., Kong L., Kumar N.N., Kunchok A., Lavados P.M., Levi C., Li Q., Lim J.Y., Lindley R.I., Liu L., Lv J., Malavera A., Manning L., Martins S.O., Minhas J.S., Mistri A., Monaghan H., Moullaali T.J., Naidu B., Octavio Marques Pontes-Neto, Odgers E., Olavarria V.V., Parsons M.W., Ricci S., Richtering S., Robinson T.G., S Anderson C., Sandercock P., Sanders E., Sato S., Scaria A., Sharma V.K., Silva-Sieger F.A., Simes R.J., Small S., Smith P., Song L., Stapf C., Tay N., Thang N.H., Thembani E., Tucker S., Vaghasiya R., Wang J.G., Wang X., Wardlaw J.M., Winters S., Wong K.S.L., Woodward M., Wu G., Xi Z., Yang J., Yoshimura S., You S., Zhang S., Zhao H., Zhu P.Fuentes:scopusInteraction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study
ArticleAbstract: Objective: To determine the extent to which the effects of intensive blood pressure (BP) lowering arPalabras claves:acute ischemic stroke, Blood pressure lowering, Hypertension, Intracerebral Hemorrhage, thrombolysisAutores:Arima H., Chalmers J., Delcourt C., Kim J.S., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Martins S.O., Minhas J.S., Moullaali T.J., Octavio Marques Pontes-Neto, Olavarria V.V., Robinson T.G., S Anderson C., Sandset E.C., Sharma V.K., Song L., Sun L., Thang N.H., Wang J.G., Wang X., Yang J.Fuentes:scopusRationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment
ArticleAbstract: Rationale: Controversy exists over the optimal dose of intravenous (iv) recombinant tissue plasminogPalabras claves:Acute ischaemic stroke, Alteplase, Dose, Hypertension, Rt-PA, thrombolysisAutores:Arima H., Bath P.M.W., Broderick J.P., Chalmers J., Chen X., Demchuk A.M., Donnan G.A., Fuentes S., Huang Y., Kim J.S., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Silva-Sieger F.A., Stapf C., Wang J.G., Woodward M.Fuentes:scopus